The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids
Open accessAbstract
OBJECTIVE: Glucocorticoids (GCs) alter bone strength such that patients receiving these medications have a high rate of fragility-related fractures. The purpose of this study was to assess whether concurrent treatment with GCs (prednisolone) and risedronate (an aminobisphosphonate) would prevent the reduction in bone strength induced by GCs, in a mouse model of GC-induced bone loss and in patients enrolled in a clinical study. METHODS: We evaluated mice treated with prednisolone pellets alone, GCs plus risedronate, or placebo alone and iliac crest biopsy specimens obtained from patients who were treated with GCs plus placebo or GCs plus risedronate for 1 year. We measured the mass, architecture, and physical and material properties of bone (subject to therapeutic treatments) at nanoscale to macroscopic dimensions, using synchrotron x-ray tomography, elastic modulus mapping, transmission electron microscopy, and small-angle x-ray scattering techniques. RESULTS: GC treatment reduced trabecular bone mass, microarchitecture, and the degree of bone mineralization and elastic modulus within the trabeculae. Concurrent treatment with GCs and risedronate prevented the deterioration of trabecular bone architecture, reduced the degree of mineralization, and preserved elastic modulus within the trabeculae, in both mouse and human bone. In addition, treatment with risedronate plus GCs in mice appeared to preserve bone crystal orientation, compared with treatment with GCs alone. CONCLUSION: Risedronate prevented the localized changes in mineral and material properties of bone induced by GCs, which may ultimately improve bone strength.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Glucocorticoids potently suppress osteoblast activities and adversely affect bone mineralization.
“As GCs potently suppress osteoblast activities and adversely affect bone mineralization [41, 46]”
From Prevention of glucocorticoid induced bone changes with beta-ecdysone (2015) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,015 · see citing works
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258 · see citing works
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258 · see citing works
Self-citationLuckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,175 · see citing works
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · see citing works
Nancollas, G. H., Tang, R., Phipps, R. J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R. G. G., & Ebetino, F. H. (2006) · Bone · doi:10.1016/j.bone.2005.05.003 · Cited by 862 · see citing works
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
Adachi, J. D., Bensen, W., Brown, J. P., Hanley, D. A., Hodsman, A. B., Josse, R. G., Kendler, D. L., Lentle, B. C., Olszynski, W. P., Ste‐Marie, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370603 · Cited by 683 · see citing works
Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate
Eastell, R., Barton, I. P., Hannon, R., Chines, A. A., Garnero, P., & Delmas, P. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.1051 · Cited by 585 · see citing works
Wallach, S., Cohen, S. B., Reid, D. M., Hughes, R., Hosking, D. J., Laan, R., Doherty, S. M., Maricic, M. J., Rosen, C. J., Brown, J. P., et al. (2000) · Calcified Tissue International · doi:10.1007/s002230001146 · Cited by 512 · see citing works
Bauer, D. C., Black, D. M., Garnero, P., Hochberg, M. C., Ott, S. M., Orloff, J. J., Thompson, D. E., Ewing, S. K., Delmas, P. D., & for the Fracture Intervention Trial Study Group (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040512 · Cited by 403 · see citing works
Weinstein, R. S., Chen, J., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14538 · Cited by 396 · see citing works
Glucocorticoids suppress bone formation via the osteoclast.
Kim, H.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28084 · Cited by 384 · cited 1× · see citing works
“Also, GCs have been reported to be antiapoptotic and prolong survival of osteoclasts, while other investigators reported that GCs suppressed osteoclast activity in in vitro and in vivo studies (18,31).”
ResultCoxon, F. P., Helfrich, M., Hof, R. V., Sebti, S. M., Ralston, S. H., Hamilton, A. D., & Rogers, M. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1467 · Cited by 361 · see citing works
INTERMITTENT ETIDRONATE THERAPY TO PREVENT CORTICOSTEROID- INDUCED OSTEOPOROSIS
Dachi, J. O. D. A., Ensen, W. I. G. B., Acques, J., Rown, B., Anley, D. A. H., Osse, R. O. J., Endler, D. A. L. K., Entle, B. R. L., Lszynski, W. O. O., Ouis, L., et al. (1997) · Cited by 360 · see citing works
Lane, N. E., Yao, W., Balooch, M., Nalla, R. K., Balooch, G., Habelitz, S., Kinney, J. H., & Bonewald, L. F. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051103 · Cited by 355 · see citing works
Self-citationRheumatoid arthritis, corticosteroid therapy and hip fracture.
Cooper, C. C., Coupland, C. A. C., & Mitchell, M. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.1.49 · Cited by 354 · see citing works
Reszka, A. A., Halasy-Nagy, J., Masarachia, P. J., & Rodan, G. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34967 · Cited by 255 · see citing works
Evaluation of a new modulus mapping technique to investigate microstructural features of human teeth
Balooch, G., Marshall, G. W., Marshall, S. J., Warren, O. L., Asif, S. A. S., & Balooch, M. (2004) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2003.12.012 · Cited by 206 · see citing works
Self-citationBone Mineralization as Studied by Small-Angle X-Ray Scattering
Fratzl, P., Schreiber, S., & Klaushofer, K. (1996) · Connective Tissue Research · doi:10.3109/03008209609005268 · Cited by 189 · see citing works
Boutsen, Y., Jamart, J., Esselinckx, W., & Devogelaer, J.-P. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.104 · Cited by 160 · see citing works
PARFITT, A. M. (1988) · Bone · doi:10.1016/8756-3282(88)90029-4 · Cited by 157 · see citing works
Mineral Changes in Osteoporosis
Faibish, D., Ott, S. M., & Boskey, A. L. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000200241.14684.4e · Cited by 156 · see citing works
Borah, B., Dufresne, T. E., Ritman, E. L., Jorgensen, S. M., Liu, S., Chmielewski, P. A., Phipps, R. J., Zhou, X., Sibonga, J. D., & Turner, R. T. (2006) · Bone · doi:10.1016/j.bone.2006.01.161 · Cited by 153 · see citing works
Glucocorticoid-induced osteoporosis
Saag, K. G. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00064-6 · Cited by 145 · see citing works
Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients
Eastell, R., Devogelaer, J.-P., Peel, N. F. A., Chines, A. A., Bax, D. E., Sacco-Gibson, N., Nagant de Deuxchaisnes, C., & Russell, R. G. G. (2000) · Osteoporosis International · doi:10.1007/s001980070122 · Cited by 134 · see citing works
Kinney, J. H., Haupt, D. L., Balooch, M., Ladd, A. J. C., Ryaby, J. T., & Lane, N. E. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.1981 · Cited by 115 · see citing works
Self-citationChavassieux, P., ARLOT, M. E., Roux, J. P., Portero-Muzy, N., Daifotis, A. G., Yates, A. J. P., Hamdy, N. A. T., Malice, M., Freedholm, D., & Meunier, P. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.754 · Cited by 105 · see citing works
An Update on Glucocorticoid-Induced Osteoporosis
Lane, N. E. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70196-4 · Cited by 95 · see citing works
Self-citationMonier‐Faugere, M., Geng, Z., Paschalis, E. P., Qi, Q., Arnala, I., Bauss, F., Boskey, A. L., & Malluche, H. H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.10.1768 · Cited by 94 · see citing works
Ichikawa, K., Tsutsumi, A., Atsumi, T., Matsuura, E., Kobayashi, S., Hughes, G. R. V., Khamashta, M. A., & Koike, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11 · Cited by 88 · see citing works
Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice
Akhter, M. P., Cullen, D. M., Gong, G., & Recker, R. R. (2001) · Bone · doi:10.1016/s8756-3282(01)00486-0 · Cited by 88 · see citing works
Engqvist, H., Botton, G. A., Couillard, M., Mohammadi, S., Malmström, J., Emanuelsson, L., Hermansson, L., Phaneuf, M. W., & Thomsen, P. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30696 · Cited by 63 · see citing works
Porter, A. E., Buckland, T., Hing, K. A., Best, S. M., & Bonfield, W. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30690 · Cited by 62 · see citing works
Self-citationYao, W., Hadi, T. M., Jiang, Y., Lotz, J. C., Wronski, T. J., & Lane, N. E. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1969-2 · Cited by 55 · see citing works
Self-citationUltrastructural Properties of Bone Mineral of Control and Tiludronate-Treated Osteoporotic Rat
Rohanizadeh, R., LeGeros, R. Z., Bohic, S., Pilet, P., Barbier, A., & Daculsi, G. (2000) · Calcified Tissue International · doi:10.1007/s002230001141 · Cited by 27 · see citing works
Asahi, H., Mizokami, A., Miwa, S., Keller, E. T., Koshida, K., & Namiki, M. (2006) · International Journal of Urology · doi:10.1111/j.1442-2042.2006.01360.x · Cited by 25 · see citing works
Yao, W., Balooch, G., Balooch, M., Jiang, Y., Nalla, R. K., Kinney, J. H., Wronski, T. J., & Lane, N. E. (2006) · Bone · doi:10.1016/j.bone.2006.03.008 · Cited by 23 · see citing works
Self-citationBone Density Changes with Once Weekly Risedronate in Postmenopausal Women
Delaney, M. F., Hurwitz, S., Shaw, J., & LeBoff, M. S. (2003) · Journal of Clinical Densitometry · doi:10.1385/jcd:6:1:45 · Cited by 22 · see citing works
Flagged first, then by citations
1 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [9]Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 1999; 42:2309–18. [DOI] [PubMed] [Google Scholar]
Cited by
Sorted by citations
Measurement of the toughness of bone: A tutorial with special reference to small animal studies
Ritchie, R. O., Koester, K. J., Ionova-Martin, S. S., Yao, W., Lane, N. E., & Ager, J. W. (2008) · Bone · doi:10.1016/j.bone.2008.04.027 · Cited by 224 · see citing works
Self-citationYao, W., Cheng, Z., Pham, A., Busse, C., Zimmermann, E. A., Ritchie, R. O., & Lane, N. E. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23954 · Cited by 128 · see citing works
Self-citationYao, W., Dai, W., Jiang, L., Lay, E. Y.-A., Zhong, Z. A., Ritchie, R. O., Li, X., Ke, H. Z., & Lane, N. E. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3308-6 · Cited by 116 · see citing works
Self-citationNano-scale modulus mapping of biological composite materials: Theory and practice
Zlotnikov, I., Zolotoyabko, E., & Fratzl, P. (2017) · Progress in Materials Science · doi:10.1016/j.pmatsci.2017.03.002 · Cited by 46 · see citing works
Yao, W., Lay, Y.-A. E., Kot, A., Liu, R., Zhang, H., Chen, H., Lam, K. S., & Lane, N. E. (2016) · Stem Cells · doi:10.1002/stem.2433 · Cited by 43 · see citing works
Self-citationMultiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis
Karunaratne, A., Xi, L., Bentley, L., Sykes, D., BOYDE, A., Esapa, C. T., Terrill, N. J., Brown, S. D. M., Cox, R., Thakker, R. V., et al. (2015) · Bone · doi:10.1016/j.bone.2015.11.019 · Cited by 42 · see citing works
Cai, J., Shao, X., Yang, Q., Yang, Y., Yan, Z., Luo, E., Feng, X., & Jing, D. (2020) · Bone · doi:10.1016/j.bone.2020.115266 · Cited by 41 · see citing works
Cheng, Z., Yao, W., Zimmermann, E. A., Busse, C., Ritchie, R. O., & Lane, N. E. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.81005 · Cited by 40 · see citing works
Self-citationStrain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice
Ersek, A., Santo, A. I. E., Vattakuzhi, Y., George, S., Clark, A. R., & Horwood, N. J. (2016) · Scientific Reports · doi:10.1038/srep36513 · Cited by 39 · see citing works
Bisphosphonates and glucocorticoids: Effects on bone quality
Lems, W. F. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22975 · Cited by 37 · see citing works
Prevention of glucocorticoid induced bone changes with beta-ecdysone
Dai, W., Jiang, L., Lay, Y.-A. E., Chen, H., Jin, G., Zhang, H., Kot, A., Ritchie, R. O., Lane, N. E., & Yao, W. (2015) · Bone · doi:10.1016/j.bone.2015.01.001 · Cited by 30 · see citing works
Self-citationFifty years of bisphosphonates: What are their mechanical effects on bone?
Burr, D. B. (2020) · Bone · doi:10.1016/j.bone.2020.115518 · Cited by 30 · see citing works
Amugongo, S. K., Yao, W., Jia, J., Dai, W., Lay, Y.-A. E., Jiang, L., Harvey, D. J., Zimmermann, E. A., Schaible, E. G., Dave, N. K. N., et al. (2014) · Bone · doi:10.1016/j.bone.2014.04.033 · Cited by 26 · see citing works
Self-citationAlemi, A. S., Mazur, C. M., Fowler, T. W., Woo, J. J., Knott, P. D., & Alliston, T. N. (2018) · Bone Reports · doi:10.1016/j.bonr.2018.09.004 · Cited by 23 · see citing works
Prednisolone treatment and restricted physical activity further compromise bone of mdx mice.
Novotny, S. A., Warren, G. L., Lin, A., Guldberg, R. E., Baltgalvis, K. A., & Lowe, D. A. (2012) · PubMed · Cited by 21 · see citing works
Xi, L., Song, Y., Wu, W., Qu, Z., Wen, J., Liao, B., Tao, R., Ge, J., & Fang, D. (2020) · Bone · doi:10.1016/j.bone.2020.115334 · Cited by 20 · see citing works
Jia, J., Yao, W., Amugongo, S. K., Shahnazari, M., Dai, W., Lay, Y.-A. E., Olvera, D., Zimmermann, E. A., Ritchie, R. O., Li, C., et al. (2012) · Bone · doi:10.1016/j.bone.2012.10.017 · Cited by 19 · see citing works
Self-citationUltrastructural characteristics of glucocorticoid-induced osteoporosis
Bouvard, B., Audran, M., Legrand, É., & Chappard, D. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0864-7 · Cited by 17 · see citing works
Assessing bone quality through mechanical properties in postmenopausal trabecular bone
Toledano, M., Toledano‐Osorio, M., Guerado, E., Caso, E., Osorio, E., & Osorio, R. (2018) · Injury · doi:10.1016/j.injury.2018.07.035 · Cited by 16 · see citing works
Optical Biosensor Based on Microbendings Technique: An Optimized Mean to Measure the Bone Strength
Singh, P. B., & Shrivastava, A. (2014) · Advances in Optical Technologies · doi:10.1155/2014/853725 · Cited by 13 · see citing works
Postnov, A., Schutter, T. M. D., Sijbers, J., Karperien, M., & Clerck, N. D. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9301-3 · Cited by 13 · see citing works
Bone Biomechanics and Bone Quality: Effects of Pharmaceutical Agents Used to Treat Osteoporosis
Burr, D. B. (2016) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-016-9217-1 · Cited by 10 · see citing works
Liu, S. P., Liao, E. Y., Chen, J., Yang, S. M., Li, J. W., Sheng, Z., Mo, H., Wu, X., Yao, L., & Dai, R. C. (2008) · Acta Radiologica · doi:10.1080/02841850802613122 · Cited by 10 · see citing works
Toledano, M., Toledano‐Osorio, M., Guerado, E., Caso, E., Aguilera, F. S., & Osorio, R. (2018) · Injury · doi:10.1016/j.injury.2018.07.034 · Cited by 10 · see citing works
Xi, L., Zhang, Y., Gupta, H. S., Terrill, N. J., Wang, P., Zhao, T., & Fang, D. (2020) · Bone · doi:10.1016/j.bone.2020.115666 · Cited by 10 · see citing works
Animal Models in Bone Research
Kimmel, D. B. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-56192-9_4 · Cited by 8 · see citing works
Iwamoto, J., Matsumoto, H., Tadeda, T., Satō, Y., & Yeh, J. K. (2009) · Yonsei Medical Journal · doi:10.3349/ymj.2009.50.2.189 · Cited by 8 · see citing works
RetractedSolitro, G. F., Mainnemare, F., Amirouche, F. M. L., & Mehta, A. I. (2018) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-018-1918-9 · Cited by 7 · see citing works
Synchrotron Radiation Micro-CT Imaging of Bone Tissue
Peter, Z., & Peyri, F. (2011) · InTech eBooks · doi:10.5772/14995 · Cited by 6 · see citing works
Instrumented nanoindentation in musculoskeletal research
Pei, S., Zhou, Y., Li, Y., Azar, T., Wang, W., Kim, D., & Liu, X. S. (2022) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2022.05.010 · Cited by 6 · see citing works
Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness
Luo, T. D., & Allen, M. R. (2013) · Bone · doi:10.1016/j.bone.2013.06.004 · Cited by 5 · see citing works
Cheng, Z., Yao, W., Zimmermann, E. A., Busse, C., Ritchie, R. O., & Lane, N. E. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081005 · Cited by 4 · see citing works
Self-citationNanostructure in the trabecular bone of postmenopausal women: Mechanical and chemical analysis
Toledano, M., Osorio, R., Guerado, E., Caso, E., & Osorio, E. (2017) · Injury · doi:10.1016/s0020-1383(17)30791-x · Cited by 4 · see citing works
Effects of lactoferrin on dexamethasone-induced osteoporosis in mice
Izumo, N., Kagaya, S., Toho, M., Furukawa, M., Kabaya, Y., Hirai, T., Hayamizu, K., Nakano, M., Hoshino, T., & Watanabe, Y. (2018) · Global Drugs and Therapeutics · doi:10.15761/gdt.1000149 · Cited by 4 · see citing works
Glucocorticoid-induced Osteoporosis: From Pathogenesis to Treatment
Chung, Y. (2009) · Cited by 1 · see citing works
Recurrent fractures in an elderly patient with systemic lupus erythematosus
Chia, F. L., Thong, B. Y., Tang‐Ching, L. A. U., & Pao‐Hsii, F. E. N. G. (2009) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2009.01422.x
Concurrent bisphosphonate therapy reduces osteoporotic effects of glucocorticoids
(2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0697
- Authors
- Balooch, G., Yao, W., Ager, J. W., Balooch, M., Nalla, R. K., Porter, A. E., Ritchie, R. O., & Lane, N. E.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- University of California, Davis (US)
- University of California, San Francisco (US)
- University of Cambridge (GB)
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-10-29
- Volume
- 56
- Issue
- 11
- Pages
- 3726-3737
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- PMC
- PMC6913894
- OpenAlex
- W2067926159
- Cited by
- 37
- References
- 39
- Citations by year
- 2022: 1 · 2020: 4 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01dk046661-05)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK46661-10)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24-AR-48841-03, R01AR043052, P50AR063043, K24AR048841)
- Core Research for Evolutional Science and Technology
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- risedronate, aminobisphosphonates, glucocorticoids, prednisolone, glucocorticoid-induced osteoporosis, trabecular bone, bone mineralization, bone material properties, elastic modulus, bone strength, fragility fractures, iliac crest bone
- MeSH terms
- Risedronic Acid, Animals, Biomechanical Phenomena, Biopsy, Calcification, Physiologic, Drug Interactions, Elasticity, Glucocorticoids, Humans, Ilium, Lumbar Vertebrae, Male, Prednisolone, Etidronic Acid, Tomography, X-Ray, Microscopy, Electron, Transmission, Bone Density Conservation Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
